These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9038751)

  • 1. Resistant enterococci--mechanisms, laboratory detection and control in hospitals.
    Wade JJ; Uttley AH
    J Clin Pathol; 1996 Sep; 49(9):700-3. PubMed ID: 9038751
    [No Abstract]   [Full Text] [Related]  

  • 2. Report of a meeting on the epidemiology and control of glycopeptide-resistant enterococci.
    Chadwick PR; Chadwick CD; Oppenheim BA
    J Hosp Infect; 1996 Jun; 33(2):83-92. PubMed ID: 8808742
    [No Abstract]   [Full Text] [Related]  

  • 3. [Aminoglycoside-resistant enterococci a new bacterial hazard].
    Melhus A
    Lakartidningen; 1999 Apr; 96(14):1694-5. PubMed ID: 10222683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proficiency of clinical laboratories in and near Monterrey, Mexico, to detect vancomycin-resistant enterococci.
    McDonald LC; Garza LR; Jarvis WR
    Emerg Infect Dis; 1999; 5(1):143-6. PubMed ID: 10081682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and control of multiresistant enterococci.
    Leclercq R
    Drugs; 1996; 52 Suppl 2():47-9. PubMed ID: 8869836
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative in vitro activity of oritavancin and other agents against vancomycin-susceptible and -resistant enterococci.
    Sweeney D; Stoneburner A; Shinabarger DL; Arhin FF; Belley A; Moeck G; Pillar CM
    J Antimicrob Chemother; 2017 Feb; 72(2):622-624. PubMed ID: 27856721
    [No Abstract]   [Full Text] [Related]  

  • 7. Guidelines for the control of glycopeptide-resistant enterococci in hospitals.
    Cookson BD; Macrae MB; Barrett SP; Brown DF; Chadwick C; French GL; Hateley P; Hosein IK; Wade JJ;
    J Hosp Infect; 2006 Jan; 62(1):6-21. PubMed ID: 16310890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC).
    MMWR Recomm Rep; 1995 Sep; 44(RR-12):1-13. PubMed ID: 7565541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vancomycin-resistant enterococci: causes and control.
    Ferguson JK
    Med J Aust; 1999 Aug; 171(3):117-8. PubMed ID: 10474599
    [No Abstract]   [Full Text] [Related]  

  • 10. Vancomycin-resistant enterococcal infections.
    Murray BE
    N Engl J Med; 2000 Mar; 342(10):710-21. PubMed ID: 10706902
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of infections due to resistant enterococci: a review of therapeutic options.
    Landman D; Quale JM
    J Antimicrob Chemother; 1997 Aug; 40(2):161-70. PubMed ID: 9301980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-level aminoglycoside resistance and beta-lactamase production in enterococci at a tertiary care hospital in India.
    Agarwal J; Kalyan R; Singh M
    Jpn J Infect Dis; 2009 Mar; 62(2):158-9. PubMed ID: 19305061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidelines for the prevention and control of vancomycin resistant enterococci (VRE) in long-term care facilities. Sioux Falls Task Force on Antimicrobial Resistance.
    S D J Med; 1998 Apr; 51(4):127-32. PubMed ID: 9577692
    [No Abstract]   [Full Text] [Related]  

  • 14. For nosocomial vancomycin-resistant enterococcal infections: the ounce of prevention or the pound of cure?
    Farr BM
    Clin Infect Dis; 2004 Apr; 38(8):1116-8. PubMed ID: 15095216
    [No Abstract]   [Full Text] [Related]  

  • 15. Glycopeptide-resistant enterococci: a decade of experience.
    Woodford N
    J Med Microbiol; 1998 Oct; 47(10):849-62. PubMed ID: 9788808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical implications of antibiotic resistance of enterococci].
    Besnier JM; Leport C
    Presse Med; 1997 Nov; 26(37):1781-7. PubMed ID: 9569899
    [No Abstract]   [Full Text] [Related]  

  • 17. Antimicrobial resistance in enterococci.
    Pai CH; Kim MN
    Yonsei Med J; 1998 Dec; 39(6):554-61. PubMed ID: 10097683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin-resistant enterococci: implications for infection control.
    Molyneux R; Chadwick C
    Prof Nurse; 1997 Jun; 12(9):641-4. PubMed ID: 9248438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vancomycin-resistant enterococci.
    Rubinstein E; Keynan Y
    Crit Care Clin; 2013 Oct; 29(4):841-52. PubMed ID: 24094380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin resistant Enterococci in a tertiary care hospital in Mumbai.
    De A; Bindlish A; Kumar S; Mathur M
    Indian J Med Microbiol; 2009; 27(4):375-6. PubMed ID: 19736416
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.